Trial · NCT04142190

Corifollitropin Alfa and Embryo Morphokinetics

NCT04142190, Completed, Kinderwunsch Institut GmbH

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Corifollitropin Alfa and Embryo Morphokinetics. Trials, record NCT04142190. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04142190

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Corifollitropin Alfa and Embryo Morphokinetics
NCT number: NCT04142190
Status: Completed
Enrollment: 1,351 participants, actual
Lead sponsor: Kinderwunsch Institut GmbH
Conditions: Infertility
Interventions: ELONVA, PUREGON
First posted: 2019-10-29
Last updated: 2019-10-29

Source ClinicalTrials.gov

Registered outcomes18

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame	Description
Primary	Time of pronuclei disappearance	16-18 hours after fertilization	Time of pronuclei disappearance in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON
Primary	Two discrete cells	26-28 hours after fertilization	The first observation of two discrete cells in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON
Primary	Three discrete cells	28-44 hours after fertilization	The first observation of three discrete cells in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON
Primary	Four discrete cells	44-45 hours after fertilization	The first observation of four discrete cells in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON
Primary	Five discrete cells	44-68 hours after fertilization	The first observation of five discrete cells in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON
Primary	Six discrete cells	44-68 hours after fertilization	The first observation of six discrete cells in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON
Primary	Seven discrete cells	44-68 hours after fertilization	The first observation of seven discrete cells in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON
Primary	Eight discrete cells	68-69 hours after fertilization	The first observation of eight discrete cells in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON
Primary	Nine discrete cells	69-92 hours after fertilization	The first observation of nine discrete cells in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON
Primary	Morula stage	92 hours after fertilization	End of the compaction process; when observable compaction is complete in embryos of patients stimulated with ELONVA versus embryos of patients stimulated with PUREGON

1 to 10 of 18Source ClinicalTrials.gov

See all 18 registered outcomes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers6

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as	Source
24581983	BACKGROUND	PubMed
25200818	BACKGROUND	PubMed
25316446	BACKGROUND	PubMed
25395178	BACKGROUND	PubMed
25444507	BACKGROUND	PubMed
25690157	BACKGROUND	PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04142190

GET https://conductscience.org/api/trials/v1/NCT04142190/registered

API reference For AI assistants